The Chronic Kidney Disease Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Chronic Kidney Disease Global Market Report 2024 has exhibited strong growth in recent years. It is predicted to increase from $70.65 billion in 2024 to $75.09 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%.
The Chronic Kidney Disease Global Market Report 2024 predicts that by 2029, the market size for chronic kidney disease will reach $95.85 billion, with a compound annual growth rate (CAGR) of 6.3%.
Download Your Free Sample of the 2025 Chronic Kidney Disease Market Report and Uncover Key Trends Now!The key drivers in the chronic kidney disease market are:
• Increased focus on healthcare policies
• Growth in precision medicine development
• Surge in obesity rates
• Expansion of healthcare access
• Integration of nutritional therapy
The chronic kidney disease market covered in this report is segmented –
1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy
2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments
3) By Route of Administration: Oral, Intravenous, Subcutaneous
4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users
The key trends in the chronic kidney disease market are:
• There is a noticeable trend towards early screening campaigns for chronic kidney disease.
• Telemedicine and remote monitoring are increasingly being used in this market.
• Patient empowerment programs are an emerging trend in this industry.
• The integration of nutritional therapy in chronic kidney disease treatment is gaining traction.
The major players in the chronic kidney disease market are:
• Pfizer Inc,
• Johnson and Johnson Services Inc
North America was the largest region in the chronic kidney disease market in 2024